Shoulder Innovations Announces Pricing of Initial Public Offering

Strategic Insights -

Shoulder Innovations, a commercial-stage medical technology company focused on transforming the shoulder surgical care market, has announced the pricing of its initial public offering of 5 million shares of common stock at $15.00 per share. The company has granted underwriters an option to purchase an additional 750,000 shares, with gross proceeds expected to be $75 million. The offering is expected to close on August 1, 2025, subject to customary closing conditions, and Shoulder Innovations' common stock is set to begin trading on the New York Stock Exchange under the ticker symbol "SI" on July 31, 2025.

Key Takeaways:

  • Shoulder Innovations, a commercial-stage medical technology company, has priced its initial public offering (IPO) of 5 million shares of common stock at $15.00 per share.
  • The company has granted underwriters an option to purchase up to an additional 750,000 shares at the initial public offering price, with gross proceeds expected to be $75 million.
  • Shoulder Innovations' common stock is expected to begin trading on the New York Stock Exchange under the ticker symbol "SI" on July 31, 2025.
  • The offering will close on August 1, 2025, subject to customary closing conditions.
  • Morgan Stanley, Goldman Sachs & Co. LLC, and Piper Sandler are acting as joint lead book-running managers for the offering, with Jefferies as book-running manager and BTIG as lead manager.
  • The IPO is being made only by means of a prospectus, which may be obtained from the underwriters.

Statistics:

  • 5,000,000 shares of common stock are being offered by Shoulder Innovations at $15.00 per share.
  • The underwriters have been granted an option to purchase up to an additional 750,000 shares, with gross proceeds expected to be $75 million before deducting underwriting discounts and commissions.
  • Shoulder Innovations' common stock is expected to begin trading on the New York Stock Exchange under the ticker symbol "SI" on July 31, 2025.
  • The offering is expected to close on August 1, 2025, subject to customary closing conditions.

Sources:

  • PR Newswire
  • Shoulder Innovations
  • Morgan Stanley & Co. LLC
  • Goldman Sachs & Co. LLC
  • Piper Sandler & Co.
  • Jefferies
  • BTIG
  • U.S. Securities and Exchange Commission